Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J FRANKLIN

Showing results (721-730 of 746) with videos related to

Pageof 75
Sort By:
Neuron|September 2, 2008
Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous systemBastian G Brinkmann, Amit Agarwal, Michael W Sereda, et al.
Science (New York, N.Y.)|January 20, 2009
Effects of genetic perturbation on seasonal life history plasticityAmity M Wilczek, Judith L Roe, Mary C Knapp, et al.
JACC. Advances|May 28, 2026
Adult Congenital Heart Disease Workforce Challenges in the United States: Current State and Future Needs: Proceedings from the American College of Cardiology (ACC), Adult Congenital Pediatric Cardiology (ACPC) Council Adult Congenital Heart Disease SummitAli N Zaidi, Ritu Sachdeva, Richard Kovacs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's diseaseM Loeffler, V Diehl, M Pfreundschuh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 1999
BEACOPP: a new regimen for advanced Hodgkin's disease. German Hodgkin's Lymphoma Study GroupV Diehl, J Franklin, D Hasenclever, et al.
Trials|August 3, 2017
Development of a core outcome set for clinical trials in facial aging: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi surveyDaniel I Schlessinger, Sanjana Iyengar, Arianna F Yanes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study GroupV Diehl, J Franklin, D Hasenclever, et al.
Journal of AOAC International|October 20, 2017
Evaluation of <i>mericon E. coli</i> O157 Screen Plus and <i>mericon E. coli</i> STEC O-Type Pathogen Detection Assays in Select Foods: Collaborative Study, First Action 2017.05Patrick Bird, M Joseph Benzinger, Benjamin Bastin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2006
Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trialsJ Franklin, A Pluetschow, M Paus, et al.
Journal of Medicinal Chemistry|December 5, 2008
New benzylureas as a novel series of potent, nonpeptidic vasopressin V2 receptor agonistsChristopher M Yea, Christine E Allan, Doreen M Ashworth, et al.
Pageof 75

Showing results (721-730 of 746) with videos related to

Sort By:
Pageof 75
Neuron|September 2, 2008
Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous systemBastian G Brinkmann, Amit Agarwal, Michael W Sereda, et al.
Science (New York, N.Y.)|January 20, 2009
Effects of genetic perturbation on seasonal life history plasticityAmity M Wilczek, Judith L Roe, Mary C Knapp, et al.
JACC. Advances|May 28, 2026
Adult Congenital Heart Disease Workforce Challenges in the United States: Current State and Future Needs: Proceedings from the American College of Cardiology (ACC), Adult Congenital Pediatric Cardiology (ACPC) Council Adult Congenital Heart Disease SummitAli N Zaidi, Ritu Sachdeva, Richard Kovacs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's diseaseM Loeffler, V Diehl, M Pfreundschuh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 1999
BEACOPP: a new regimen for advanced Hodgkin's disease. German Hodgkin's Lymphoma Study GroupV Diehl, J Franklin, D Hasenclever, et al.
Trials|August 3, 2017
Development of a core outcome set for clinical trials in facial aging: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi surveyDaniel I Schlessinger, Sanjana Iyengar, Arianna F Yanes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study GroupV Diehl, J Franklin, D Hasenclever, et al.
Journal of AOAC International|October 20, 2017
Evaluation of <i>mericon E. coli</i> O157 Screen Plus and <i>mericon E. coli</i> STEC O-Type Pathogen Detection Assays in Select Foods: Collaborative Study, First Action 2017.05Patrick Bird, M Joseph Benzinger, Benjamin Bastin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2006
Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trialsJ Franklin, A Pluetschow, M Paus, et al.
Journal of Medicinal Chemistry|December 5, 2008
New benzylureas as a novel series of potent, nonpeptidic vasopressin V2 receptor agonistsChristopher M Yea, Christine E Allan, Doreen M Ashworth, et al.
Pageof 75